Your browser doesn't support javascript.
loading
Misincorporation Proteomics Technologies: A Review.
Steele, Joel R; Italiano, Carly J; Phillips, Connor R; Violi, Jake P; Pu, Lisa; Rodgers, Kenneth J; Padula, Matthew P.
Afiliación
  • Steele JR; Proteomics Core Facility and School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Italiano CJ; Neurotoxin Research Group, School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Phillips CR; Neurotoxin Research Group, School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Violi JP; Neurotoxin Research Group, School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Pu L; Proteomics Core Facility and School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Rodgers KJ; Neurotoxin Research Group, School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Padula MP; Neurotoxin Research Group, School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia.
Proteomes ; 9(1)2021 Jan 21.
Article en En | MEDLINE | ID: mdl-33494504
Proteinopathies are diseases caused by factors that affect proteoform conformation. As such, a prevalent hypothesis is that the misincorporation of noncanonical amino acids into a proteoform results in detrimental structures. However, this hypothesis is missing proteomic evidence, specifically the detection of a noncanonical amino acid in a peptide sequence. This review aims to outline the current state of technology that can be used to investigate mistranslations and misincorporations whilst framing the pursuit as Misincorporation Proteomics (MiP). The current availability of technologies explored herein is mass spectrometry, sample enrichment/preparation, data analysis techniques, and the hyphenation of approaches. While many of these technologies show potential, our review reveals a need for further development and refinement of approaches is still required.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Proteomes Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Proteomes Año: 2021 Tipo del documento: Article